ID

28928

Description

The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00437918

Lien

https://clinicaltrials.gov/show/NCT00437918

Mots-clés

  1. 16/02/2018 16/02/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

16 février 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes Mellitus NCT00437918

Eligibility Diabetes Mellitus NCT00437918

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
korean
Description

Korean

Type de données

boolean

Alias
UMLS CUI [1]
C1556095
type 2 diabetes mellitus
Description

Diabetes Mellitus, Non-Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
no prior history of diabetic ketoacidosis
Description

Absence Past history of Diabetic Ketoacidosis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0332119
UMLS CUI [1,3]
C0011880
hba1c between 7.5-10.0%
Description

Glucohemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0202054
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes mellitus
Description

Diabetes Mellitus, Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
gestational diabetes mellitus
Description

Gestational Diabetes

Type de données

boolean

Alias
UMLS CUI [1]
C0085207
secondary diabetes mellitus
Description

Secondary diabetes mellitus

Type de données

boolean

Alias
UMLS CUI [1]
C0271640
severe hyperglycemia with symptoms
Description

SEVERE HYPERGLYCEMIA Symptomatic

Type de données

boolean

Alias
UMLS CUI [1,1]
C0239979
UMLS CUI [1,2]
C0231220
severe chronic diabetic complications (pdr,s-cr>1.3mg/dl)
Description

Complications of Diabetes Mellitus Severe chronic | Proliferative diabetic retinopathy | Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1,1]
C0342257
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0205191
UMLS CUI [2]
C0154830
UMLS CUI [3]
C0201976

Similar models

Eligibility Diabetes Mellitus NCT00437918

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Korean
Item
korean
boolean
C1556095 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Absence Past history of Diabetic Ketoacidosis
Item
no prior history of diabetic ketoacidosis
boolean
C0332197 (UMLS CUI [1,1])
C0332119 (UMLS CUI [1,2])
C0011880 (UMLS CUI [1,3])
Glucohemoglobin measurement
Item
hba1c between 7.5-10.0%
boolean
C0202054 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Gestational Diabetes
Item
gestational diabetes mellitus
boolean
C0085207 (UMLS CUI [1])
Secondary diabetes mellitus
Item
secondary diabetes mellitus
boolean
C0271640 (UMLS CUI [1])
SEVERE HYPERGLYCEMIA Symptomatic
Item
severe hyperglycemia with symptoms
boolean
C0239979 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Complications of Diabetes Mellitus Severe chronic | Proliferative diabetic retinopathy | Creatinine measurement, serum
Item
severe chronic diabetic complications (pdr,s-cr>1.3mg/dl)
boolean
C0342257 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0154830 (UMLS CUI [2])
C0201976 (UMLS CUI [3])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial